Jaguar Health Executes $3.4M Debt-for-Equity Exchange

What Happened Jaguar Health, Inc. (JAGX) filed an 8-K (Sept. 28, 2026) reporting that on September 25, 2026 it entered into privately negotiated exchange agreements with Streeterville Capital, LLC. Under the agreements the company issued 481,584 shares of common stock to Streeterville in exchange for a $3,400,000 reduction in the outstanding balance of a secured promissory note issued on January 19, 2021 (the “2021 Note”). The filing notes the exchange agreements contain customary representations, warranties and covenants.

Key Details

• Transaction date: September 25, 2026; 8-K filed September 28, 2026.
• Shares issued: 481,584 shares of common stock to Streeterville Capital, LLC.
• Debt reduction: $3,400,000 reduction of the outstanding balance on the 2021 Note.
• Note history and share count: the 2021 Note had an original principal of $6,220,812.50 (issued Jan. 19, 2021); after the exchange the company reported approximately 1,945,542 shares of common stock outstanding.

Why It Matters This transaction reduces Jaguar Health’s outstanding debt tied to the 2021 Note by $3.4 million, which can lower future cash interest and principal obligations. In exchange, the company issued additional common shares, increasing dilution to existing shareholders (total shares outstanding now ~1.95 million). Investors should weigh the benefit of lower debt versus the dilution impact and may review the filed exchange agreement (Exhibit 10.1) for full terms and any remaining obligations under the 2021 Note.